Cargando…

Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study

BACKGROUND: Early detection of pancreatic ductal adenocarcinoma (PDAC) may improve the prognosis of patients. This study was to identify metabolic features of PDAC and to discover early detection biomarkers for PDAC by tissue and serum metabolomics analysis. METHODS: We conducted nontargeted metabol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Rui, Ren, Shuai, Li, Changyin, Guo, Kai, Lu, Zipeng, Tian, Lei, He, Jian, Zhang, Kai, Cao, Yingying, Liu, Shijia, Li, Donghui, Wang, Zhongqiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972159/ https://www.ncbi.nlm.nih.gov/pubmed/36161527 http://dx.doi.org/10.1002/cam4.5296

Ejemplares similares

Potential Metabolite Biomarkers for Early Detection of Stage-I Pancreatic Ductal Adenocarcinoma
por: Cao, Yingying, et al.
Publicado: (2022)

Exploring the key genetic association between chronic pancreatitis and pancreatic ductal adenocarcinoma through integrated bioinformatics
por: Guo, Kai, et al.
Publicado: (2023)

Computed Tomography-Based Radiomics Signature for the Preoperative Differentiation of Pancreatic Adenosquamous Carcinoma From Pancreatic Ductal Adenocarcinoma
por: Ren, Shuai, et al.
Publicado: (2020)

Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma
por: Cao, Ying-Ying, et al.
Publicado: (2023)

Editorial: Novel circulating biomarkers and radiomics in pancreatic cancer
por: Ren, Shuai, et al.
Publicado: (2023)

Threshold of Main Pancreatic Duct Diameter in Identifying Malignant Intraductal Papillary Mucinous Neoplasm by Magnetic Resonance Imaging
por: Zhang, Huifeng, et al.
Publicado: (2023)

Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer
por: Ren, Shuai, et al.
Publicado: (2021)

Differentiation of chronic mass-forming pancreatitis from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography
por: Ren, Shuai, et al.
Publicado: (2019)

Discovery and Validation of Potential Serum Biomarkers with Pro-Inflammatory and DNA Damage Activities in Ulcerative Colitis: A Comprehensive Untargeted Metabolomic Study
por: Li, Mingxiao, et al.
Publicado: (2022)

Novel Metabolomics Serum Biomarkers for Pancreatic Ductal Adenocarcinoma by the Comparison of Pre-, Postoperative and Normal Samples
por: Zhang, Xiaohan, et al.
Publicado: (2020)

Serum Metabolomic Biomarkers of Dementia
por: Mousavi, Malahat, et al.
Publicado: (2014)

Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer
por: Liu, Chang, et al.
Publicado: (2022)

Serum metabolomic and lipidomic profiling identifies diagnostic biomarkers for seropositive and seronegative rheumatoid arthritis patients
por: Luan, Hemi, et al.
Publicado: (2021)

Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma
por: Wang, Cheng, et al.
Publicado: (2021)

A Gold Nanocage Probe Targeting Survivin for the Diagnosis of Pancreatic Cancer
por: Song, Lina, et al.
Publicado: (2023)

Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography
por: Ren, Shuai, et al.
Publicado: (2019)

Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
por: Martín-Blázquez, Ariadna, et al.
Publicado: (2020)

Untargeted Lipidomics Reveals Characteristic Biomarkers in Patients with Ankylosing Spondylitis Disease
por: Li, Zhengjun, et al.
Publicado: (2022)

Biomarkers of Metabolomics in Inflammatory Bowel Disease and Damp-Heat Syndrome: A Preliminary Study
por: Wu, Xingxing, et al.
Publicado: (2022)

Metabolomic Biomarkers in Serum and Urine in Women with Preeclampsia
por: Austdal, Marie, et al.
Publicado: (2014)

Serum and Plasma Metabolomic Biomarkers for Lung Cancer
por: Kumar, Nishith, et al.
Publicado: (2017)

Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination
por: Itoi, Takao, et al.
Publicado: (2017)

Biomarker Identification and Pathway Analysis by Serum Metabolomics of Lung Cancer
por: Chen, Yingrong, et al.
Publicado: (2015)

Untargeted serum metabolomics reveals specific metabolite abnormalities in patients with Crohn's disease
por: Liu, Huanhuan, et al.
Publicado: (2022)

Combined metabolomic and lipidomic analysis uncovers metabolic profile and biomarkers for papillary thyroid carcinoma
por: Wang, Zipeng, et al.
Publicado: (2023)

Diagnostic accuracy of apparent diffusion coefficient to differentiate intrapancreatic accessory spleen from pancreatic neuroendocrine tumors
por: Ren, Shuai, et al.
Publicado: (2023)

Metabolomics analysis reveals serum biomarkers in patients with diabetic sarcopenia
por: Tan, Yuwei, et al.
Publicado: (2023)

Serum metabolomics of end-stage renal disease patients with depression: potential biomarkers for diagnosis
por: Yuan, Dezhi, et al.
Publicado: (2021)

Search for serum biomarkers in patients with bipolar disorder and major depressive disorder using metabolome analysis
por: Sun, Xiao-Li, et al.
Publicado: (2023)

Serum Metabolomics Profiling to Identify Biomarkers for Unstable Angina
por: Yao, Wei, et al.
Publicado: (2017)

Untargeted analysis of the serum metabolome in cats with exocrine pancreatic insufficiency
por: Barko, Patrick C., et al.
Publicado: (2021)

Untargeted Analysis of Serum Metabolomes in Dogs with Exocrine Pancreatic Insufficiency
por: Barko, Patrick C., et al.
Publicado: (2023)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

Serum Exosomal EphA2 is a Prognostic Biomarker in Patients with Pancreatic Cancer
por: Wei, Qian, et al.
Publicado: (2021)

Metabolomic biomarkers of pancreatic cancer: a meta-analysis study
por: Mehta, Khyati Y., et al.
Publicado: (2017)

Evaluation of Texture Analysis for the Differential Diagnosis of Mass-Forming Pancreatitis From Pancreatic Ductal Adenocarcinoma on Contrast-Enhanced CT Images
por: Ren, Shuai, et al.
Publicado: (2019)

Integrated Proteomics and Metabolomic Analyses of Plasma Injury Biomarkers in a Serious Brain Trauma Model in Rats
por: Song, Tao, et al.
Publicado: (2019)

Serum metabolomics analysis revealed metabolic disorders in Parkinson’s disease
por: Lan, Tian-Tian, et al.
Publicado: (2023)

Serum amyloid a, a potential biomarker both in serum and tissue, correlates with ovarian cancer progression
por: Li, Ze, et al.
Publicado: (2020)

Biomarkers of TGF-β Signaling Pathway and Prognosis of Pancreatic Cancer
por: Javle, Milind, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hr9d8dpul4c1huqps2spj6anor